The Indian arm of the GIOSTAR stem cell group, with centres in Ahmedabad and Bangalore treating a wide range of chronic and degenerative conditions.
GIOSTAR — the Global Institute of Stem Cell Therapy and Research — is an international stem cell organisation whose site lists two centres in India with full addresses: one in Bodakdev, Ahmedabad, and one on Modi Hospital Road in Rajajinagar, Bangalore. Further Indian locations in Madhya Pradesh, Surat, Chhattisgarh and New Delhi are mentioned without complete addresses, and the site states that a Chandigarh location is temporarily unavailable for treatment, directing patients to Ahmedabad and Bangalore instead.
There is an important qualification that anyone using this entry should understand. The site states plainly that each global partner of GIOSTAR is an autonomous body operating independently of the others and of GIOSTAR-USA, and that GIOSTAR-USA supplies scientific knowledge rather than running the facilities. The Indian centres are therefore separately operated organisations using the GIOSTAR name, not branches of a single company.
The organisation's chairman, co-founder and chief scientific officer is named on the site as Dr Anand Srivastava, MS, PhD, described as a stem cell scientist who helped establish laboratories at several American research institutions. No treating clinician at either Indian centre is named anywhere on the pages read, which is a significant gap for a patient trying to establish who would be responsible for their care.
The Ahmedabad page lists roughly thirty conditions, including osteoarthritis, diabetes, liver disease, cancer, autism, Parkinson's disease, stroke and spinal cord injury. It describes the Ahmedabad facility in strong terms — as one of the world's largest stem cell hospitals, funded by the government of Gujarat and inaugurated by the then chief minister of the state — but the address given for it is an office suite in a corporate building, and the site sets out no detail of the stem cell types or sources used at any Indian centre, nor any prices. Those claims are the organisation's own and are reported here unverified.
The Ahmedabad page lists around thirty conditions; the following are those named explicitly on the pages read.
The site describes proprietary stem cell treatments and stem cell based protocols, but does not state which cell types it uses or where they are obtained from.
The only person named on the pages read is the organisation's chairman and chief scientific officer; no treating clinician at either Indian centre is named.
The site gives street addresses for two Indian centres, in Bodakdev, Ahmedabad and in Rajajinagar, Bangalore, along with two mobile telephone numbers. It describes the Ahmedabad facility as one of the world's largest stem cell hospitals and as funded by the government of Gujarat, though the address published for it is an office suite in a corporate building rather than a hospital campus, and no laboratory, ward or theatre is described. The site also notes that the group's Chandigarh location is temporarily closed to patients.
The site does not publish prices for treatment at its Indian centres, and directs enquirers to telephone for a consultation instead.
Profile compiled from information published on the clinic's own website and from the StemCell Registry directory record. Details may change; confirm directly with the clinic before making decisions.